Role and action in the pituitary corticotroph of corticotropin-releasing factor (CRF) in the hypothalamus

Peptides

Volumn 30, Issue 4, 2009, Pages 810-816

  Kageyama, Kazunori ^a   Suda, Toshihiro ^a  

^a HIROSAKI UNIVERSITY   (Japan)

Author keywords

ACTH; Corticotropin releasing factor; Cyclic AMP; Proopiomelanocortin; Receptor

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; FURIN; MESSENGER RNA; PROOPIOMELANOCORTIN;

ACTH SECRETING CELL; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; CONTROLLED STUDY; HYPOTHALAMUS; IMMUNE RESPONSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALS; CORTICOTROPIN-RELEASING HORMONE; HYPOTHALAMUS; PITUITARY GLAND;

MAMMALIA; MUS;

EID: 62749198597     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2008.12.007     Document Type: Review

References (47)

1. Aguilera G., Nikodemova M., Wynn P.C., and Catt K.J. Corticotropin releasing hormone receptors: two decades later. Peptides 25 (2004) 319-329
2. Aragay A.M., Ruiz-Gomez A., Penela P., Sarnago S., Elorza A., Jimenez-Sainz M.C., et al. G protein-coupled receptor kinase 2 (GRK2): mechanisms of regulation and physiological functions. FEBS Lett 430 (1998) 37-40
3. Benjannet S., Rondeau N., Day R., Chretien M., and Seidah N.G. PC1 and PC2 are proprotein convertases capable of cleaving proopiomelanocortin at distinct pairs of basic residues. Proc Natl Acad Sci USA 88 (1991) 3564-3568
4. Blaxall B.C., Pellett A.C., Wu S.C., Pende A., and Port J.D. Purification and characterization of beta-adrenergic receptor mRNA-binding proteins. J Biol Chem 275 (2000) 4290-4297
5. Blaxall B.C., Pende A., Wu S.C., and Port J.D. Correlation between intrinsic mRNA stability and the affinity of AUF1 (hnRNP D) and HuR for A + U-rich mRNAs. Mol Cell Biochem 232 (2002) 1-11
6. Castro M.G., Gusovsky F., and Loh Y.P. Transmembrane signals mediating adrenocorticotropin release from mouse anterior pituitary cells. Mol Cell Endocrinol 65 (1989) 165-173
7. Catt K.J., Harwood J.P., Aguilera G., and Dufau M.L. Hormonal regulation of peptide receptors and target cell response. Nature 201 (1979) 109-116
8. Chappell P.B., Smith M.A., Kilts C.D., Bissette G., Ritchie J., Anderson C., et al. Alterations of corticotropin-releasing factor-like immunoreactivity in discrete rat brain regions after acute and chronic stress. J Neurosci 6 (1986) 2908-2914
9. Dautzenberg F.M., Braun S., and Hauger R.L. GRK3 mediates desensitization of CRF1 receptors: a potential mechanism regulating stress adaptation. Am J Physiol Regul Integr Comp Physiol 280 (2001) R935-R946
10. Dautzenberg F.M., Wille S., Braun S., and Hauger R.L. GRK3 regulation during CRF- and urocortin-induced CRF1 receptor desensitization. Biochem Biophys Res Commun 298 (2002) 303-308
11. DebBurman S.K., Ptasienski J., Benovic J.L., and Hosey M.M. G protein-coupled receptor kinase GRK2 is a phospholipid-dependent enzyme that can be conditionally activated by G protein betagamma subunits. J Biol Chem 271 (1996) 22552-22562
12. Fukuda Y., Kageyama K., Nigawara T., Kasagi Y., and Suda T. Effects of corticotropin-releasing hormone (CRH) on the synthesis and secretion of proopiomelanocortin-related peptides in the anterior pituitary: a study using CRH-deficient mice. Neurosci Lett 367 (2004) 201-204
13. Hauger R.L., and Aguilera G. Regulation of pituitary corticotropin releasing hormone (CRH) receptors by CRH: interaction with vasopressin. Endocrinology 133 (1993) 1708-1714
14. Hauger R.L., Olivares-Reyes J.A., Braun S., Catt K.J., and Dautzenberg F.M. Mediation of corticotropin releasing factor type 1 receptor phosphorylation and desensitization by protein kinase C: a possible role in stress adaptation. J Pharmacol Exp Ther 306 (2003) 794-803
15. Hillhouse E.W., and Grammatopoulos D.K. Control of intracellular signalling by corticotropin-releasing hormone in human myometrium. Front Horm Res 27 (2001) 66-74
16. Iredale P.A., and Duman R.S. Glucocorticoid regulation of corticotropin-releasing factor1 receptor expression in pituitary-derived AtT-20 cells. Mol Pharmacol 51 (1997) 794-799
17. Kageyama K., Hanada K., Moriyama T., Nigawara T., Sakihara S., and Suda T. G Protein-coupled receptor kinase 2 involvement in desensitization of corticotropin-releasing factor (CRF) receptor type 1 by CRF in murine corticotrophs. Endocrinology 147 (2006) 441-450
18. Kageyama K., Sakihara S., and Suda T. Regulation and role of p21- activated kinase 3 by corticotropin-releasing factor in mouse pituitary. Regul Pept 152 (2009) 88-94
19. Kasagi Y., Horiba N., Sakai K., Fukuda Y., and Suda T. Involvement of cAMP-response element binding protein in corticotropin-releasing factor (CRF)-induced down-regulation of CRF receptor 1 gene expression in rat anterior pituitary cells. J Neuroendocrinol 14 (2002) 587-592
20. Kohout T.A., and Lefkowitz R.J. Regulation of G protein-coupled receptor kinases and arrestins during receptor desensitization. Mol Pharmacol 63 (2003) 9-18
21. Kong G., Penn R., and Benovic J.L. A beta-adrenergic receptor kinase dominant negative mutant attenuates desensitization of the beta 2-adrenergic receptor. J Biol Chem 269 (1994) 13084-13087
22. 1 receptor) mRNA via protein kinase A and mitogen-activated protein kinase pathways in rat anterior pituitary cells. Mol Cell Endocrinol 243 (2005) 74-79
23. Muglia L., Jacobson L., Dikkes P., and Majzoub J.A. Corticotropin-releasing hormone deficiency reveals major fetal but not adult glucocorticoid need. Nature 373 (1995) 427-432
24. Muglia L.J., Jacobson L., Luedke C., Vogt S.K., Schaefer M.L., Dikkes P., et al. Corticotropin-releasing hormone links pituitary adrenocorticotropin gene expression and release during adrenal insufficiency. J Clin Invest 105 (2000) 1269-1277
25. Muglia L.J., Jacobson L., Weninger S.C., Luedke C.E., Bae D.S., Jeong K.H., et al. Impaired diurnal adrenal rhythmicity restored by constant infusion of corticotropin-releasing hormone in corticotropin-releasing hormone-deficient mice. J Clin Invest 99 (1997) 2923-2929
26. Muglia L.J., Jenkins N.A., Gilbert D.J., Copeland N.G., and Majzoub J.A. Expression of the mouse corticotropin-releasing hormone gene in vivo and targeted inactivation in embryonic stem cells. J Clin Invest 93 (1994) 2066-2072
27. Nigawara T., Horiba N., Tozawa F., Kasagi Y., Uchida K., Iwasaki Y., et al. Regulation of corticotropin releasing hormone receptor (CRH-R) in the rat anterior pituitary as assessed by radioimmunoassay. Pituitary 6 (2003) 67-73
28. Nikodemova M., Diehl C.R., and Aguilera G. Multiple sites of control of type-1 corticotropin releasing hormone receptor levels in the pituitary. Arch Physiol Biochem 110 (2002) 123-128
29. Pende A., Tremmel K.D., DeMaria C.T., Blaxall B.C., Minobe W.A., Sherman J.A., et al. Regulation of the mRNA-binding protein AUF1 by activation of the beta-adrenergic receptor signal transduction pathway. J Biol Chem 271 (1996) 8493-8501
30. Perrin M.H., and Vale W.W. Corticotropin releasing factor receptors and their ligand family. Ann N Y Acad Sci 885 (1999) 312-328
31. Pitcher J.A., Fredericks Z.L., Stone W.C., Premont R.T., Stoffel R.H., Koch W.J., et al. Phosphatidylinositol 4,5-bisphosphate (PIP2)-enhanced G protein-coupled receptor kinase (GRK) activity. Location, structure, and regulation of the PIP2 binding site distinguishes the GRK subfamilies. J Biol Chem 271 (1996) 24907-24913
32. Pozzoli G., Bilezikjian L.M., Perrin M.H., Blount A.L., and Vale W.W. Corticotropin-releasing factor (CRF) and glucocorticoids modulate the expression of type 1 CRF receptor messenger ribonucleic acid in rat anterior pituitary cell cultures. Endocrinology 137 (1996) 65-71
33. Rabadan-Diehl C., Kiss A., Camacho C., and Aguilera G. Regulation of messenger ribonucleic acid for corticotropin releasing hormone receptor in the pituitary during stress. Endocrinology 137 (1996) 3808-3814
34. Sakai K., Horiba N., Sakai Y., Tozawa F., Demura H., and Suda T. Regulation of corticotropin-releasing factor receptor messenger ribonucleic acid in rat anterior pituitary. Endocrinology 137 (1996) 1758-1763
35. Salim S., Hite B., and Eikenburg D.C. Activation of the CRF(1) receptor causes ERK1/2 mediated increase in GRK3 expression in CATH.a cells. FEBS Lett 581 (2007) 3204-3210
36. Suda T., Kageyama K., Sakihara S., and Nigawara T. Physiological roles of urocortins, human homologues of fish urotensin 1, and their receptors. Peptides 25 (2004) 1689-1701
37. Suda T., Kondo M., Totani R., Hashimoto N., Suzuki M., Imaki T., et al. Ectopic adrenocorticotropin syndrome caused by lung cancer that responded to corticotropin-releasing hormone. J Clin Endocrinol Metab 63 (1986) 1047-1051
38. Suda T., Nakano Y., Tozawa F., Sumitomo T., Sato Y., Yamada M., et al. The role of corticotropin-releasing factor and vasopressin in hypoglycemia-induced proopiomelanocortin gene expression in the rat anterior pituitary gland. Brain Res 579 (1992) 303-308
39. Suda T., Tozawa F., Yamada M., Ushiyama T., Tomori N., Sumitomo T., et al. Insulin-induced hypoglycemia increases corticotropin-releasing factor messenger ribonucleic acid levels in rat hypothalamus. Endocrinology 123 (1988) 1371-1375
40. Suda T., Tozawa F., Yamaguchi H., Shibasaki T., Demura H., and Shizume K. Multiple forms of immunoreactive β-endorphin are present in an ectopic adrenocorticotropin-producing tumor but not in normal pituitary or pituitary adenomas. J Clin Endocrinol Metab 54 (1982) 167-171
41. Tanoue A., Ito S., Honda K., Oshikawa S., Kitagawa Y., Koshimizu T.-A., et al. The vasopressin V1b receptor critically regulates hypothalamic-pituitary-adrenal axis activity under both stress and resting conditions. J Clin Invest 113 (2004) 302-309
42. Teli T., Markovic D., Levine M.A., Hillhouse E.W., and Grammatopoulos D.K. Regulation of corticotropin-releasing hormone receptor type 1alpha signaling: structural determinants for G protein-coupled receptor kinase-mediated phosphorylation and agonist-mediated desensitization. Mol Endocrinol 19 (2005) 474-490
43. Tizabi Y., and Aguilera G. Desensitization of the hypothalamic pituitary adrenal axis following prolonged administration of corticotropin releasing hormone or vasopressin. Neuroendocrinology 56 (1992) 611-618
44. Tran T.M., Friedman J., Qunaibi E., Baameur F., Moore R.H., and Clark R.B. Characterization of agonist stimulation of cAMP-dependent protein kinase and G protein-coupled receptor kinase phosphorylation of the beta2-adrenergic receptor using phosphoserine-specific antibodies. Mol Pharmacol 65 (2004) 196-206
45. Vale W., Rivier C., Brown M.R., Spiess J., Koob G., Swanson L., et al. Chemical and biological characterization of corticotropin releasing factor. Recent Prog Horm Res 39 (1983) 245-270
46. Vale W., Spiess J., Rivier C., and Rivier J. Characterization of a 41 residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science 213 (1981) 1394-1397
47. Xu G., Rabadan-Diehl C., Nikodemova M., Wynn P., Spiess J., and Aguilera G. Inhibition of corticotropin releasing hormone type-1 receptor translation by an upstream AUG triplet in the 5′ untranslated region. Mol Pharmacol 59 (2001) 485-492